To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi
Title and authors | Publication | Year |
---|---|---|
Immunoglobulin Diversity Gene Usage Predicts Unfavorable Outcome in a Subset of Unmutated Chronic Lymphocytic Leukemia
Renee C. Tschumper, Susan M. Geyer, Megan E. Campbell, Neil E. Kay, Tait D. Shanafelt, Clive S. Zent, Grzegorz S. Nowakowski, Timothy G. Call, Gordon W. Dewald, and Diane F. Jelinek |
Journal of Clinical Investigation | 2007 |
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia
V Fulci, S Chiaretti, M Goldoni, G Azzalin, N Carucci, S Tavolaro, L Castellano, A Magrelli, F Citarella, M Messina, R Maggio, N Peragine, S Santangelo, FR Mauro, P Landgraf, T Tuschl, DB Weir, M Chien, JJ Russo, J Ju, R Sheridan, C Sander, M Zavolan, A Guarini, R Foà, G Macino |
Blood | 2007 |
Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells
LD Vallat, Y Park, C Li, JG Gribben |
Blood | 2007 |
Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia
T Motiwala, S Majumder, H Kutay, DS Smith, DS Neuberg, DM Lucas, JC Byrd, M Grever, ST Jacob |
Clinical cancer research | 2007 |
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
F Murray, N Darzentas, A Hadzidimitriou, G Tobin, M Boudjogra, C Scielzo, N Laoutaris, K Karlsson, F Baran-Marzsak, A Tsaftaris, C Moreno, A Anagnostopoulos, F Caligaris-Cappio, D Vaur, C Ouzounis, C Belessi, P Ghia, F Davi, R Rosenquist, K Stamatopoulos |
Blood | 2007 |
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells
RN Damle, S Temburni, C Calissano, S Yancopoulos, T Banapour, C Sison, SL Allen, KR Rai, N Chiorazzi |
Blood | 2007 |
Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia
G Roos, A Krober, P Grabowski, D Kienle, A Buhler, H Dohner, R Rosenquist, S Stilgenbauer |
Blood | 2007 |
Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology
LV Abruzzo, LL Barron, K Anderson, RJ Newman, WG Wierda, S O'brien, A Ferrajoli, M Luthra, S Talwalkar, R Luthra, D Jones, MJ Keating, KR Coombes |
The Journal of molecular diagnostics : JMD | 2007 |
Molecular genetic analysis of haematological malignancies II: mature lymphoid neoplasms
AJ Bench, WN Erber, GA Follows, MA Scott |
International Journal of Laboratory Hematology | 2007 |
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
D Gonzalez, M der Burg, R Garcia-Sanz, JA Fenton, AW Langerak, M Gonzalez, JJ van Dongen, JF san Miguel, GJ Morgan |
Blood | 2007 |
Krónikus limfoid leukémia: autoimmun betegség? Prognosztikai faktorok és a patogenezis mai értelmezése
L Pajor |
Orvosi Hetilap | 2007 |
The normal counterpart to the chronic lymphocytic leukemia B cell
F Caligaris-Cappio, P Ghia |
Best Practice & Research Clinical Haematology | 2007 |
Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells
N Chiorazzi |
Best Practice & Research Clinical Haematology | 2007 |
The immunoglobulin genes: Structure and specificity in chronic lymphocytic leukemia
GT PhD |
Leukemia & Lymphoma | 2007 |
Animal models for chronic lymphocytic leukemia
Y Pekarsky, N Zanesi, RI Aqeilan, CM Croce |
Journal of Cellular Biochemistry | 2007 |
Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MA Kharfan-Dabaja, R Fahed, M Hussein, ES Santos |
Expert Opinion on Investigational Drugs | 2007 |
Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence?
MA Kharfan-Dabaja, A Kumar, M Behera, B Djulbegovic |
British Journal of Haematology | 2007 |
ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia
P Ghia, K Stamatopoulos, C Belessi, C Moreno, S Stilgenbauer, F Stevenson, F Davi, R Rosenquist |
Leukemia | 2007 |
Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia
L Muñoz, A Lasa, MT Carricondo, C Hernández, J Ubeda, JF Nomdedéu |
Cytometry Part B: Clinical Cytometry | 2007 |
Preclinical assessment of curcumin as a potential therapy for B-CLL
PC Everett, JA Meyers, A Makkinje, M Rabbi, A Lerner |
American Journal of Hematology | 2007 |
IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL)
Z Balogh, L Reiniger, L Deák, C Bödör, J Csomor, Á Szepesi, É Gagyi, L Kopper, A Matolcsy |
Hematological Oncology | 2007 |
Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome
L Terrin, L Trentin, M Degan, I Corradini, R Bertorelle, P Carli, N Maschio, MD Bo, F Noventa, V Gattei, G Semenzato, AD Rossi |
Leukemia | 2007 |
Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: An Evolving Concept
MA Kharfan-Dabaja, C Anasetti, ES Santos |
Biology of Blood and Marrow Transplantation | 2007 |
CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia
P Josefsson, CH Geisler, H Leffers, JH Petersen, MK Andersen, J Jurlander, AM Buhl |
Blood | 2007 |
Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia
JB Weinberg, AD Volkheimer, Y Chen, BE Beasley, N Jiang, MC Lanasa, D Friedman, G Vaccaro, CW Rehder, CM DeCastro, DA Rizzieri, LF Diehl, JP Gockerman, JO Moore, BK Goodman, MC Levesque |
American Journal of Hematology | 2007 |
IgVH Mutational Status and Clonality Analysis of Richterʼs Transformation
Z Mao, L Quintanilla-Martinez, M Raffeld, M Richter, J Krugmann, C Burek, E Hartmann, T Rudiger, ES Jaffe, HK Müller-Hermelink, G Ott, F Fend, A Rosenwald |
The American Journal of Surgical Pathology | 2007 |
Gene therapy and active immune therapy of hematologic malignancies
WG Wierda, TJ Kipps |
Best Practice & Research Clinical Haematology | 2007 |
Prognostic markers in chronic lympocytic leukaemia
TJ Hamblin |
Best Practice & Research Clinical Haematology | 2007 |
The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia
TJ Kipps |
Best Practice & Research Clinical Haematology | 2007 |
Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia
MH Farsangi, M Jeddi-Tehrani, RA Sharifian, SM Razavi, J Khoshnoodi, H Rabbani, F Shokri |
Leukemia & Lymphoma | 2007 |
Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia
EA Nikitin, SG Malakho, BV Biderman, AV Baranova, YY Lorie, AY Shevelev, MM Peklo, TN Vlasik, EA Moskalev, BV Zingerman, IA Vorob'ev, AB Poltaraus, AB Sudarikov, AI Vorobjev |
Leukemia & Lymphoma | 2007 |
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia
GD Poeta, MI Principe, F Buccisano, L Maurillo, G Capelli, F Luciano, AP Perrotti, M Degan, A Venditti, P Fabritiis, V Gattei, S Amadori |
Cancer | 2007 |
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia
S Molica, G Cutrona, G Vitelli, R Mirabelli, M Molica, G Digiesi, D Ribatti, M Ferrarini, A Vacca |
Leukemia Research | 2007 |
Pathology of chronic lymphocytic leukemia: an update
KV Inamdar, CE Bueso-Ramos |
Annals of Diagnostic Pathology | 2007 |
Molecular Characterization of Complete and Incomplete Immunoglobulin Heavy Chain Gene Rearrangements in Hairy Cell Leukemia
P Martín-Jiménez, R García-Sanz, D González, A Balanzategui, JJ Pérez, MD Caballero, ME Sarasquete, J Galende, A Orfao, MC López-Berges, JF san Miguel, M González |
Clinical Lymphoma & Myeloma | 2007 |
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status
CI Mockridge, KN Potter, I Wheatley, LA Neville, G Packham, FK Stevenson |
Blood | 2007 |